Terri B. Sebree
2019
In 2019, Terri B. Sebree earned a total compensation of $1M as President at Zynerba Pharmaceuticals, a 19% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $252,144 |
|---|---|
| Option Awards | $309,861 |
| Salary | $437,750 |
| Stock Awards | $13,140 |
| Other | $25,985 |
| Total | $1,038,880 |
Sebree received $437.8K in salary, accounting for 42% of the total pay in 2019.
Sebree also received $252.1K in non-equity incentive plan, $309.9K in option awards, $13.1K in stock awards and $26K in other compensation.
Rankings
In 2019, Terri B. Sebree's compensation ranked 9,125th out of 13,971 executives tracked by ExecPay. In other words, Sebree earned more than 34.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,125 out of 13,971 | 35th |
Division Manufacturing | 3,656 out of 5,695 | 36th |
Major group Chemicals And Allied Products | 1,382 out of 2,194 | 37th |
Industry group Drugs | 1,179 out of 1,880 | 37th |
Industry Pharmaceutical Preparations | 873 out of 1,392 | 37th |
Source: SEC filing on April 23, 2020.
Sebree's colleagues
We found two more compensation records of executives who worked with Terri B. Sebree at Zynerba Pharmaceuticals in 2019.
News
Zynerba Pharmaceuticals CEO Armando Anido's 2022 pay slips 15% to $1.9M
April 21, 2023
Zynerba Pharmaceuticals CEO Armando Anido's 2021 pay jumps 49% to $2.2M
April 25, 2022
Zynerba Pharmaceuticals CEO Armando Anido's 2020 pay rises 8% to $1.5M
April 21, 2021
Zynerba Pharmaceuticals CEO Armando Anido's 2019 pay falls 32% to $1.4M
April 23, 2020
Zynerba Pharmaceuticals CEO Armando Anido's 2018 pay slips 18% to $2M
April 25, 2019